AI assistant
Twist Bioscience Corp — Director's Dealing 2021
Apr 8, 2021
31873_dirs_2021-04-07_dbde2fae-30af-4cde-8654-df6b03eb9e6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-04-05
Reporting Person: Finn Patrick John (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-05 | Common Stock | M | 358 | $8.820 | Acquired | 43102 | Direct |
| 2021-04-05 | Common Stock | M | 1517 | $26.66 | Acquired | 44619 | Direct |
| 2021-04-05 | Common Stock | M | 827 | $23.33 | Acquired | 45446 | Direct |
| 2021-04-05 | Common Stock | S | 2702 | $126.72 | Disposed | 42744 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-04-05 | Employee Stock Option (right to buy) | $8.82 | M | 358 | Disposed | 2027-09-28 | Common Stock (358) | Direct |
| 2021-04-05 | Employee Stock Option (right to buy) | $26.66 | M | 1517 | Disposed | 2028-11-18 | Common Stock (1517) | Direct |
| 2021-04-05 | Employee Stock Option (right to buy) | $23.33 | M | 827 | Disposed | 2029-10-23 | Common Stock (827) | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 3, 2020.
F2: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vest on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F3: 20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
F4: 25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.